William Smith, MD
Clinical Cardiac Electrophysiology · Wilmington, NCNPI 1144338161
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (59.5%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Pfizer at 44.5% of the total. Reporting peaked in 2019 at $30,928 and has fallen 82.1% since, to $5,536 in 2025.
Across 372 payments — averaging $139.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$23K
- Medtronic$9K
- E.r. Squibb & Sons, L.L.C.$7K
- Boston Scientific$4K
- Abbott$4K
- Atricure, Inc.$1K
- plus $3K from 17 others
Across 34 payments — averaging $50,281 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$1.7M
What the payments were for
- Consulting fees$6251%
- Speaking & faculty fees$30,77560%
- Travel & lodging$6,62413%
- Food & beverage$13,66826%
- Education$180%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 18 | $22,992 |
| Medtronic(2 entities) | 98 | $9,221 |
| E.r. Squibb & Sons, L.L.C. | 4 | $7,243 |
| Boston Scientific | 118 | $4,475 |
| Abbott | 61 | $3,606 |
| Atricure, Inc. | 26 | $1,401 |
| Biosense Webster, Inc. | 12 | $634 |
| Eli Lilly | 1 | $605 |
| Philips North America LLC | 4 | $298 |
| Biotronik Inc. | 10 | $188 |
| Inari Medical, Inc. | 1 | $161 |
| Cvrx, Inc. | 1 | $134 |
| Cook Medical LLC | 1 | $124 |
| Heartflow, Inc. | 1 | $116 |
| Elutia, Inc. | 4 | $95 |
| Abiomed | 1 | $87 |
| Johnson & Johnson | 2 | $74 |
| Amgen | 2 | $67 |
| Dexcom, Inc. | 1 | $62 |
| Irhythm Technologies, Inc. | 3 | $56 |
| Vital Connect, Inc | 1 | $30 |
| Recor Medical Inc | 1 | $25 |
| Merck | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ELIQUIS$29,940
- Arctic Front$3,378
- AVEIR$1,778
- INGEVITY$625
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$522
- AZURE XT DR MRI SURESCAN$431
- Claria MRI$306
- COBALT DR MRI SURESCAN$288
- DIAMONDTEMP BIDIRECTIONAL ABLATION CATHETER$234
- JOT DX$180
- PulseSelect$174
- QDOT MICRO Catheter$173
- CardioMEMS HF System$170
- SelectSecure$168
- OMNIASECURE MRI SURESCAN$164
- WATCHMAN Access System$162
- FLOWTRIEVER CATHETER, S$161
- CT THROMBECTOMY SYSTEM KIT$161
- Carto 3$150
- WATCHMAN FLX$145
How this compares
$51,710 in reported general payments places this provider in the 70th percentile of 98 clinical cardiac electrophysiology providers in North Carolina.
See all clinical cardiac electrophysiology providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 456 | $474,735 |
| XareltoRivaroxaban | 76 | $80,696 |
| EntrestoSacubitril/Valsartan | 18 | $32,640 |
| Repatha SureclickEvolocumab | 22 | $25,583 |
| Dofetilide | 52 | $13,540 |
| Metoprolol Succinate | 508 | $8,283 |
| Flecainide Acetate | 125 | $6,463 |
| Propafenone Hcl ErPropafenone Hcl | 17 | $6,271 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 148 | $3,667 |
| SotalolSotalol Hcl | 145 | $2,580 |
| Diltiazem 24hr ErDiltiazem Hcl | 51 | $1,681 |
| Nebivolol Hcl | 40 | $1,588 |
| Metoprolol Tartrate | 192 | $1,411 |
| Amiodarone Hcl | 93 | $1,217 |
| Dilt-XrDiltiazem Hcl | 18 | $1,044 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $22,992 | $474,735456 claims |
| Johnson & JohnsonXarelto | $74 | $80,69676 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 98 clinical cardiac electrophysiology providers in North Carolina.
Other clinical cardiac electrophysiology in Wilmington
- Taylor BazemoreWilmington$62K
- Craig McCotterWilmington$51K
- Meena RaoWilmington$15K
- Keith GoldenWilmington$14K
- Michael ManogueAsheville$230K
- Daniel FriedmanDurham$196K
- James AllredGreensboro$184K
- John RhynerAsheville$168K
- Gregory HarrisGreenville$164K
- John CatanzaroGreenville$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.